团体认知行为疗法 (CBT) 与结构化活动小组治疗成人注意力缺陷多动障碍 (ADHD) 的比较
针对成人注意力缺陷多动障碍 (ADHD) 的团体认知行为疗法 (CBT) 与活动团体控制条件的单盲随机对照试验
Many adults with attention deficit hyperactivity disorder (ADHD) experience difficulties with inattention, planning and impulsivity that impacts work and social life negatively also after treatment with medication. There are various psychological treatments aiming to improve these symptoms, but it is not known if they work or not.
The goal of this clinical trial is to evaluate group cognitive behavioural therapy (CBT) for adults with attention deficit hyperactivity disorder (ADHD) in comparison to an active control group consisting of a discussion and activity group. Previous research suggests that group CBT works about equally well as other structured group activities. The main questions the researchers aim to answer are if group CBT work better than activity groups to:
- Improve symptoms of ADHD
- Improve general mental health and life quality
- Improve every-day functioning
The researchers also want to learn if group CBT or activity groups work better for some people with ADHD depending on individual characteristics such as
• type of symptoms, age, gender or co-occurring psychiatric diagnoses.
The comparison is a manualised structured activity group given at the same number of sessions and same group size. All participants will visit our clinics at 12 occasions. The partipants will:
- Fill in questionnaires before and after the group intervention, and online after 6 and 12 months
- Do cognitive testing before and after the intervention
研究概览
详细说明
Despite medical treatment, many adults with ADHD experience residual symptoms that negatively affect work performance and social life. Hence, several psychological interventions targeting these symptoms have been developed, but the treatment effects are still unclear due to lack of controlled clinical trials.
In this single-blind randomised controlled clinical trial, the reseachers will evaluate the effects of group CBT based on Safren's manual "CBT for ADHD/Mastering Your Adult ADHD" compared to an active control group. The control intervention is a manualised activity group that contains the same non-specific therapeutic elements as the treatment but no active CBT components. For dose equivalence, activity groups will be given with the same same number and length of sessions, and the same frequency, as the treatment conditions. Since therapist experience is known to influence outcomes, the activity groups will be held by staff with equivalent training and experience to those giving the treatment groups.
Consenting patients assessed eligible for treatment will be randomly assigned to treatment or control group using a standard digital randomisation generator with an allocation of 1:1. Patients and clinicians rating outcomes will be blind to group assignment.
Pre- and post intervention, and at 6 months and 12 months follow-up, the patient's ADHD symptoms, symptoms of anxiety and depression and general functioning will be assessed by experienced clinicians and with validated self-rating scales. Treatment fidelity and expectation will be compared for the therapy and control groups and adverse events will be registered.
An exact power calculation for estimation of sample sizes cannot be performed since effect sizes are not known. Based on a previously published studies of Safren's CBT individually administered, and general consensus of what is a clinically meaningful improvement in psychological treatments for other psychiatric diagnoses, we expect that 60 patients per arm will be sufficient for detection of clinically relevant effect sizes of approximately Cohen's d 0.3-0.4. A statistician will make a blind Bayesian stop analysis for every 20-25 patients, and based on the results we can decide to halt the study if sufficient power has been achieved earlier than after 60 patients. Full attrition analysis with intention to treat (ITT) analysis will be performed to investigate and minimize attrition bias.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Sweden
-
Gothenburg、Sweden、瑞典
- Sahgrenska University Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Fulfilling criteria for ADHD
- motivation and practical possibility to participate in the treatment.
Exclusion Criteria:
- Ongoing psychosis or suicidality, severe self-injury,
- Intellectual disability
- Insufficient Swedish language skills.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Group cognitive behavioural therapy
Group CBT based on an adapted version of individual CBT for ADHD according to Safren's manual "CBT for ADHD/Mastering Your Adult ADHD". |
CBT based on Safren's manual "CBT for ADHD/Mastering Your Adult ADHD"20 adapted for group format. The program includes psychoeducation and cognitive restructuring and aims to improve ADHD symptoms, especially planning, organisation, attention and adaptive thinking. The CBT groups will meet at the clinic weekly for 12 weeks for 2 hours including a break in the middle. The groups are led by two clinicians. |
|
有源比较器:Activity group
The Activity group is a structured manualised group intervention designed by clinicians and researchers at Sahlgrenska University Hospital. |
The Activity group is a structured manualised group intervention designed for this and planned future studies of psychosocial treatments for adults with ADHD and/or autism. The program includes group discussions, peer-sharing and social every-day life activities. The Activity groups will meet at the clinic weekly for 12 weeks for 2 hours including a break in the middle. The groups are led by two trainers. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Adult ADHD Self-Report Scale (ASRS)
大体时间:From enrollment to the follow-up 12 months after end of treatment
|
ASRS is a self-reported symptom questionnaire for adults with ADHD. It has 18 questions about how often the participant experiences a certain symptom, with five response choices ranging from 0 (never) to 4 (very often) points. |
From enrollment to the follow-up 12 months after end of treatment
|
|
Change in Clinical Global Impressions-Severity (CGI-S)
大体时间:At enrollment and after 12 weeks at end of treatment
|
CGI-S is a 7-point scale where the clinician rate the severity of the patients illness at the time of assessment. |
At enrollment and after 12 weeks at end of treatment
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM)
大体时间:From enrollment to the follow-up 12 months after end of treatment
|
CORE-OM is a self-rating questionnaire covering general psychiatric symptoms, well-being and functioning. It has 34 questions about how often the participant experiences a certain symptom, with five response choices ranging from 0 (not at all) to 4 (most or all of the time) points. |
From enrollment to the follow-up 12 months after end of treatment
|
|
Brunnsviken Brief Quality of Life Inventory (BBQ)
大体时间:From enrollment to the follow-up 12 months after end of treatment
|
BBQ is a validated brief version of the self-rating Quality of Life Scale, with higher sensitivity to change. It consists of 12 statements and the participant indicates how much they agree with each statement in five response choices ranging from 0 (do not agree at all) to 4 (agree completely). |
From enrollment to the follow-up 12 months after end of treatment
|
|
Colour word Interference Test (CWIT)
大体时间:At enrollment and after 12 weeks at end of treatment
|
The cognitive task CWIT from the Delis-Kaplan Executive Function System (D-KEFS) is a version of the Stoop test aiming to measure switching and inhibition. |
At enrollment and after 12 weeks at end of treatment
|
|
Trail Making Test (TMT)
大体时间:At enrollment and after 12 weeks at end of treatment
|
The cognitive test TMT from the Delis-Kaplan Executive Function System (D-KEFS) is used to measure processing speed and cognitive flexibility. |
At enrollment and after 12 weeks at end of treatment
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Treatment Credibility questionnaire (TCS)
大体时间:At enrollment and after 12 weeks at end of treatment
|
Swedish version of the TCS for assessment of treatment fidelity and expectation in both participants with ADHD and clinicians administering the CBT and activity groups. |
At enrollment and after 12 weeks at end of treatment
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- EPM Dnr 2024-02227-01
- 2023 (美国 NIH 拨款/合同)
- 2023-01505 (其他赠款/资助编号:Forte)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Most individual data will be part of patients medical records.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.